Real-world effectiveness and safety of hyperthermic intraperitoneal chemotherapy and intraperitoneal chemotherapy in ovarian cancer
HIPEC did not significantly improve survival over conventional IP in the overall population, but showed greater benefit in specific subgroups, underscoring the importance of individualized intraperitoneal chemotherapy strategies in OC.
Authors
- Qiling Li (ORCID: https://orcid.org/0000-0003-3763-4456)
- Ye Liang (ORCID: https://orcid.org/0000-0002-4031-4173)
- Siyu Yang (ORCID: https://orcid.org/0000-0002-4115-7915)
- Yiran Wang (ORCID: https://orcid.org/0009-0003-0978-5190)
- Yuqi Wang (ORCID: https://orcid.org/0000-0002-4014-3271)
- Yuanyuan Zhou (ORCID: https://orcid.org/0000-0003-3571-5762)
- Yuan Zhang (ORCID: https://orcid.org/0000-0001-6290-7642)
- Siyi Zhang (ORCID: https://orcid.org/0000-0002-7730-9546)
- Yaling Zhao (ORCID: https://orcid.org/0000-0003-0880-5594)
- Aparna Singh (ORCID: https://orcid.org/0000-0002-7583-2253)
- Qian Qie
Institutions
- First Affiliated Hospital of Xi'an Jiaotong University (CN)
- Xi'an Jiaotong University (CN)
Publication Details
- Journal
- The Oncologist
- Published
- 2025-12-18
- DOI
- https://doi.org/10.1093/oncolo/oyaf424
- Primary Topic
- Intraperitoneal and Appendiceal Malignancies
- Type
- article
- Field-Weighted Citation Impact
- 0.00